• Gentamycin Sulfate in CREC Resistance Research

  2026-09-03

  An evidence-led framework for using Gentamycin Sulfate to connect ribosomal translation stress with carbapenemase gene mobility, resistance phenotypes, and translational model design in carbapenem-resistant Enterobacter cloacae.

• Birinapant (TL32711) in CRC Apoptosis Assays

  2026-09-02

  Birinapant (TL32711) offers a mechanistically focused way to study IAP-dependent apoptosis alongside MDM1–p53 chemoradiotherapy biology. This guide translates the reference findings into biomarker-aware assay design, controls, and interpretation strategies.

• Live-Dead Cell Staining Kit I: Reliable Viability

  2026-09-02

  This scenario-driven guide explains how Live-Dead Cell Staining Kit I (Calcein AM/PI), SKU K2247, supports reproducible mammalian cell viability and cytotoxicity measurements. It covers assay design, controls, optimization, fluorescence interpretation, and practical vendor-selection criteria.

• mCherry mRNA as a Translational Control Layer

  2026-09-01

  A thought-leadership guide to using Cap 1-capped, modified mCherry mRNA as a mechanistic control for delivery, translation, and cell-state effects in translational research, with lessons from LNP-mediated ABE8e delivery for COL7A1 correction.

• Veratridine Workflows for Sodium Channel Studies

  2026-09-01

  Veratridine is a voltage-gated sodium channel opener that converts channel inactivation biology into measurable depolarization, calcium loading, and network activity. This workflow-focused guide connects acute pharmacology with chamber-specific cardiomyocyte models, blocker screening, excitotoxicity studies, and carefully bounded cancer applications.

• KPT-330: From Nuclear Export to Bone Biology

  2026-08-31

  KPT-330 (Selinexor) is a selective CRM1 inhibitor whose effects extend beyond oncology models. This article examines how recent osteoarthritis research clarifies nuclear-export biology, assay design, and the translational limits of applying KPT-330 across disease contexts.

• Ruxolitinib: A JAK1/2 Tool for Immune Profiling

  2026-08-30

  Ruxolitinib and INCB018424 offer selective JAK1/2 inhibition for myeloproliferative and immuno-oncology research. This article presents a distinct assay-centered framework linking kinase pharmacology with high-dimensional spectral flow cytometry in combination studies.

• A40926: A Regulator-Informed Assay Guide

  2026-08-29

  A40926 is a dalbavancin precursor with value beyond routine antibacterial screening. This guide connects its cell-wall mechanism, pathogen-specific activity, and biosynthetic regulator cross-talk to better assay design and fermentation decisions.

• TCEP Hydrochloride for SPRTN Assay Workflows

  2026-08-29

  Use TCEP hydrochloride to make disulfide-sensitive protein preparation more consistent without introducing thiol odors or volatile reductants. This guide connects controlled reduction, protein digestion enhancement, and hydrogen-deuterium exchange analysis with practical assay controls for studying ubiquitin-dependent SPRTN proteolysis of DNA-protein crosslinks.

• Ziprasidone HCl: Mechanism and Research Benchmarks

  2026-08-28

  Ziprasidone HCl is a second-generation antipsychotic agent with established dopamine and serotonin receptor pharmacology and reported GOT1 inhibition in cancer models. This evidence-led guide separates approved neuropsychiatric use from investigational pancreatic-cancer findings and provides assay-oriented handling benchmarks.

• DNP-Induced seRNA Drives NPC Metastasis

  2026-08-28

  The 2023 study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, as a transcriptional driver of nasopharyngeal carcinoma metastasis. By integrating transcriptomic, nascent-transcription, chromatin, perturbation, and patient-tissue analyses, it connects DNP exposure to an NPM1/c-Myc/NDRG1 regulatory axis and provides a framework for studying enhancer-associated RNA in cancer progression.

• Hydrocortisone for Reliable Cell Assays

  2026-08-27

  Learn how Hydrocortisone (SKU B1951) can improve experimental control in cell viability, proliferation, cytotoxicity, inflammation, and stress-response studies. This scenario-based guide covers receptor biology, DMSO preparation, assay controls, interpretation, storage, and practical product selection.

• H 89 2HCl and Trigeminal Pain Signaling

  2026-08-27

  H 89 2HCl provides a pharmacological way to test whether cAMP/PKA signaling contributes to neuroinflammatory sensitization and mechanical allodynia. This article translates recent trigeminal nerve research into assay decisions, controls, and interpretation strategies.

• PINK1, Mitophagy, and Bleomycin Lung Fibrosis

  2026-08-26

  A 2025 Cellular Signalling study identifies PINK1 as more than a driver of canonical PINK1/Parkin mitophagy: in bleomycin-induced pulmonary fibrosis, it suppresses BNIP3- and FUNDC1-mediated mitochondrial clearance. Using knockout mice and complementary epithelial and reporter-cell systems, the authors connect PINK1 deficiency with improved mitochondrial quality control, reduced epithelial apoptosis, and attenuated fibrosis.

• Dextromethorphan Hydrobromide: NMDA Neuroprotection

  2026-08-26

  Dextromethorphan hydrobromide is an NMDA receptor antagonist used as a research tool for glutamate excitotoxicity, ion-channel modulation, and neuroprotection research. Product data report inhibition of NMDA-induced and voltage-operated inward currents, while the available evidence supports experimental interpretation rather than clinical efficacy claims.

454 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page